https://www.selleckchem.com/pr....oducts/arry-380-ont-
Heart disease is the leading cause of death in the United States among both adults and infants. In adults, 5-year survival after a heart attack is less then 60%, and congenital heart defects are the top killer of liveborn infants. Problematically, the regenerative capacity of the heart is extremely limited, even in newborns. Furthermore, suitable donor hearts for transplant cannot meet the demand and require recipients to use immunosuppressants for life. Tissue engineered myocardium has the potential to replace dead or fibrotic
Aimer
Commentaire
Partagez
